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Sex Differences in Trends and In-Hospital
Outcomes Among Patients With Critical
Limb Ischemia: A Nationwide Analysis
Ayman Elbadawi , MD; Kirolos Barssoum, MD; Michael Megaly, MD; Devesh Rai , MD; Ahmed Elsherbeeny, MD;
Hend Mansoor, PhD, PharmD; Mehdi H. Shishehbor , DO, MPH, PhD; Ahmed Abdel-Latif, MD;
Martha Gulati , MD, MS; Islam Y. Elgendy , MD
BACKGROUND: Critical limb ischemia (CLI) represents the most severe form of peripheral artery disease and is associated with
significant mortality and morbidity. Contemporary data comparing the sex differences in trends, revascularization strategies,
and in-hospital outcomes among patients with CLI are scarce.
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METHODS AND RESULTS: Using the National Inpatient Sample database years 2002 to 2015, we identified hospitalizations for
CLI. Temporal trends for hospitalizations for CLI were evaluated. The differences in demographics, revascularization, and in-
hospital outcomes between both sexes were compared. Among 2 400 778 CLI hospitalizations, 43.6% were women. Women
were older and had a higher prevalence of obesity, hypertension, heart failure, and prior stroke. Women were also less likely to
receive any revascularization (34.7% versus 35.4%, P<0.001), but the trends of revascularization have been increasing among
both sexes. Revascularization was associated with lower in-hospital mortality among women (adjusted odds ratio [OR], 0.76;
95% CI, 0.71–0.81) and men (adjusted OR, 0.69; 95% CI, 0.65–0.73). On multivariable analysis adjusting for patient-and
hospital-related characteristics as well as revascularization, women had a higher incidence of in-hospital mortality, postoperative hemorrhage, need for blood transfusion, postoperative infection, ischemic stroke, and discharge to facilities compared
with men.
CONCLUSIONS: In this nationwide contemporary analysis of CLI hospitalizations, women were older and less likely to undergo
revascularization. Women had a higher incidence of in-hospital mortality and bleeding complications compared with men.
Sex-specific studies and interventions are needed to minimize these gaps among this high-risk population.
Key Words: critical limb ischemia ■ mortality ■ revascularization ■ sex ■ women

L

ower extremity peripheral artery disease (PAD)
affects millions of patients worldwide and carries
significant morbidity and mortality.1 Studies suggest that the prevalence of PAD is comparable among
women and men,1 yet women are less frequently diagnosed and treated.1,2 Importantly, women have been
underrepresented in clinical registries and trials of
PAD.3–6 This has led to a Call to Action by the American
Heart Association recommending further sex-specific
studies related to PAD.3

Critical limb ischemia (CLI) represents the most severe form of PAD and is associated with considerable
morbidity including limb loss, impaired quality of life, and
mortality if not adequately managed.7 Studies suggest
that women are more likely to present with advanced
and multivessel PAD.8,9 Few studies have explored the
sex-specific differences in presentation, revascularization, and outcomes among patients with PAD.6,8,10–12
However, studies examining the sex-
specific differences among patients with CLI have focused mainly
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CLINICAL PERSPECTIVE
What Is New?

• In this nationwide analysis of critical limb ischemia hospitalizations, women were older and
less likely to undergo revascularization.
• Women with critical limb ischemia had a higher
incidence of adjusted in-
hospital mortality,
bleeding complications, and discharge to facilities compared with men.
• Endovascular revascularization was associated
with lower adjusted in-hospital mortality among
both women and men compared with surgical
revascularization.

What Are the Clinical Implications?

• Sex-
specific studies and interventions are
needed to minimize these gaps among patients
with critical limb ischemia.

2012, the NIS represents a sample of 20% discharges
from all hospitals.16 The NIS provides a weight variable for establishing an estimate of national statistics.
Because the NIS is a public database containing deidentified information, this study was exempt from institutional review board approval.

Study Population
Hospitalizations for adults aged ≥18 years with primary
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) diagnostic codes for
CLI were identified (Table S1).17,18 Using ICD-9-CM
procedure codes, we identified hospitalizations receiving endovascular revascularization (peripheral balloon
angioplasty, atherectomy, or stent placement), surgical revascularization, and combined endovascular/
surgical revascularization (ie, hybrid revascularization)
(Table S1).17,18 Cases with missing data on sex indicator
or any of the study outcomes were excluded.

Patient and Hospital Characteristics

Nonstandard Abbreviations and Acronyms
AKI
CLI
NIS

acute kidney injury
critical limb ischemia
National Inpatient Sample
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on outcomes after surgical intervention.13,14 With the
advancements in endovascular techniques, the use of
percutaneous revascularization has increased exponentially for appropriate patients with CLI.15 To better
address these knowledge gaps, we aimed to investigate the trends and revascularization strategies, and
to compare in-hospital outcomes among women and
men with CLI using a large nationally representative
database.

METHODS
Data that support the findings of this study are available from the corresponding author upon reasonable
request.

Data Source
Data for this investigation were obtained from the
National Inpatient Sample (NIS) database for January
2002 through September 2015. The NIS is part of the
Healthcare Cost and Utilization Project, sponsored by
the Agency for Healthcare Research and Quality.16 The
NIS is the largest inpatient-care database in the United
States. The NIS contains discharge data from a ≈20%
stratified sample of US hospitals through 2012. Since

Baseline characteristics included patient demographics, relevant comorbidities (eg, hypertension,
hyperlipidemia, diabetes, coronary artery disease,
cardiomyopathy, heart failure, valvular heart disease,
obesity, smoking history, chronic kidney disease, prior
myocardial infarction, previous percutaneous coronary
intervention, previous coronary artery bypass grafting,
and prior stroke) were identified using corresponding
ICD-9-CM codes. A list of ICD-9-CM codes used to
identify the comorbidities and therapies is summarized
in Table S1. Hospital-related characteristics included
bed size (small, medium, and large), location (urban
versus rural), hospital region (Northeast, Midwest,
South, and West), and teaching status.

Outcome Measures
The temporal trends in hospitalizations and revascularization modalities in women versus men presenting with CLI were reported. The main study outcome
was in-hospital mortality. Other secondary outcomes
included amputation-free survival (defined as freedom
from death or major amputation during the hospitalization), major amputation, minor amputation, postoperative infection, postoperative hemorrhage, acute stroke,
and acute kidney injury (AKI). Procedures and inpatient
outcomes were abstracted and reported using ICD-
9-CM Clinical Classifications Software codes and
Elixhauser comorbidities as reported by the Healthcare
Cost and Utilization Project (Table S1).

Statistical Analysis
Discharge (trend) weights were used to compute national estimates. As per Healthcare Cost and Utilization
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Project regulations, all analyses were conducted using
the complex sample feature of SPSS software (IBM,
Armonk, NY), which accounts for discharge weights,
hospital clustering, and stratification across the NIS
database.19 Categorical variables were compared
using the χ2 test and reported as numbers and percentages. Continuous variables were compared using
the Student t test or Mann-Whitney U test depending on the distribution curve and were reported as
mean±standard deviation or median and interquartile
range depending on the distribution curve. Trend analyses were performed using linear regression analysis
or curvilinear regression analysis depending on the
shape of the curve.20
Multivariable regression analysis was conducted
to adjust for in-hospital outcomes for CLI in women
versus men. The model included the following 25 variables: age, race, diabetes, hypertension, obesity, history of heart failure, chronic lung disease, pulmonary
circulation disorders, chronic liver disease, chronic
kidney disease, chronic anemia, coagulopathy, hypothyroidism, history of smoking, coronary artery
disease, prior myocardial infarction, history of implantable cardiac defibrillator, history of cardiac pacemaker,
prior stroke, prior percutaneous coronary intervention,
prior previous coronary artery bypass grafting, hospital bed size, hospital region, hospital teaching status,
and the revascularization modality. In hospitalizations
with missing covariates, multivariable regression analyses were performed on complete cases. All variables were forced into the multivariable model using
the enter method. A secondary propensity-
score
matching analysis was conducted to compare the
in-hospital outcomes between women and men. The
matching was performed using the MatchIt R package
(R software; R Foundation for Statistical Computing,
Vienna, Austria). Each case was matched to a control
that was closest in terms of the calculated propensity
score, using the nearest neighbor technique, with a
caliper width of 0.2. The propensity score was calculated from the same patient-and hospital-related
variables used in the regression models. Subgroup
analyses according to age (ie, <50 versus ≥50 years)
and hospital location (ie, urban versus rural) were also
performed to compare in-hospital mortality and postoperative hemorrhage.
To compare the outcomes of endovascular versus
surgical revascularization, a propensity-score matching model was used to reduce the risk of selection
bias. The matching was performed using MatchIt R
package. Each case was matched to a control that
was closest in terms of calculated propensity score,
using the nearest neighbor technique, with a caliper
width of 0.2. The propensity score was calculated
from the same patient-and hospital-related variables
in the regression models, except for revascularization

Sex Differences in CLI

modality (Table S2). Associations were considered
significant if the P value was ≤0.05. We used the
SPSS version 24.0 software and R software for all
statistical analyses.

RESULTS
Study Cohort
Between January 2002 and September 2015, there
were 2 401 110 hospitalizations with a primary diagnosis of CLI. After excluding cases with missing data on
sex indicator (n=15) or missing study outcomes (n=317),
the final analysis included 2 400 778 hospitalizations;
1 047 406 (43.6%) were women. Women with CLI were
older and less likely White or Hispanic. Women had a
higher prevalence of obesity, hypertension, heart failure, and prior stroke. Women had a lower prevalence
of smoking, diabetes, coronary artery disease, prior
myocardial infarction, prior percutaneous coronary intervention, and prior coronary artery bypass grafting.
Table 1 summarizes the baseline patient-and hospital-
related characteristics.
Women were less likely to receive any revascularization during the index admission (34.7% versus 35.4%,
P<0.001). Compared with nonrevascularized patients,
women undergoing any revascularization had a lower
incidence of in-hospital mortality (2.6% versus 4.2%;
adjusted odds ratio [OR], 0.76; 95% CI, 0.71–
0.81;
P<0.001) as well as men (2.2% versus 3.8%; adjusted
OR, 0.69; 95% CI, 0.65–0.73; P<0.001). Women were
more likely to receive endovascular revascularization
(15.9% versus 14.7%, P<0.001) and less likely to receive surgical revascularization (12.5% versus 13.7%,
P<0.001) compared with men.

Trends in Hospitalizations for CLI
Hospitalizations and Revascularization
Strategies
During the study period, the rates of CLI hospitalizations did not change among women (82 706 in 2002
versus 75 193 in 2015, Ptrend=0.10) but increased
among men (95 456 in 2002 versus 111 573 in 2015,
Ptrend<0.001) (Figure 1). There was a decrease in the
rates of in-hospital mortality among women (5.2% in
2002 versus 2.9% in 2015, Ptrend<0.001) and men (4.5%
in 2002 versus 2.7% in 2015, Ptrend<0.001) (Figure 2).
There has been an increase in total revascularization
regardless of strategy among women (28.8% in 2002
versus 36.7% in 2015, Ptrend<0.001) and men (29.8%
in 2002 versus 38.1% in 2015, Ptrend<0.001). Among
women, both endovascular revascularization (5.6% in
2002 versus 20.0% in 2015, Ptrend<0.001) and hybrid
revascularization (2.3% in 2002 versus 8.9% in 2015,
Ptrend<0.001) increased, but surgical revascularization
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Table 1. Baseline Patient-and Hospital-Related Characteristics Among Women Versus Men With Critical Limb Ischemia
Women, n=1 047 406, n (%)

Men, n=1 353 704, n (%)

P value

72.1±13.6

68.4±12.7

<0.001

White

568 880 (64.3)

787 021 (68.3)

<0.001

Black

192 047 (21.7)

193 687 (16.8)

Age, y, mean±SD
Race/ethnicity

Hispanic

84 499 (9.6)

120 872 (10.5)

Asian/Pacific Islander

12 763 (1.4)

15 296 (1.3)

Other races*

6034 (0.7)

7460 (0.6)
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Smoking

131 176 (12.5)

236 664 (17.5)

<0.001

Obesity

113 734 (11.0)

113 360 (8.4)

<0.001

Hypertension

745 948 (71.9)

934 893 (69.7)

<0.001

Hypothyroidism

152 436 (14.7)

83 464 (6.2)

<0.001

Chronic kidney disease

288 973 (27.80)

428 639 (31.90)

<0.001

Chronic liver disease

14 806 (1.4)

33 803 (2.5)

<0.001

Diabetes

505 219 (48.7)

716 988 (53.4)

<0.001

Anemia

300 542 (29.0)

351 124 (26.2)

<0.001

Heart failure

209 416 (20.2)

258 830 (19.3)

<0.001

Chronic pulmonary disease

240 267 (23.20)

311 715 (23.20)

0.57

Valvular disease

63 038 (6.1)

67 849 (5.1)

<0.001

Coronary artery disease

394 495 (37.7)

621 865 (45.9)

<0.001

Prior myocardial infarction

82 195 (7.8)

137 245 (10.1)

<0.001

Prior coronary artery bypass surgery

92 077 (8.8)

203 383 (15.0)

<0.001

Prior implantable cardioverter defibrillator

9691 (0.9)

33 573 (2.5)

<0.001

Prior cardiac pacemaker

36 750 (3.5)

51 878 (3.8)

<0.001

Prior percutaneous coronary intervention

54 461 (5.2)

88 076 (6.5)

<0.001

Prior stroke

53 207 (5.1)

65 248 (4.8)

<0.001

Coagulopathy

35 319 (3.4)

53 133 (4.0)

<0.001

Pulmonary circulation disease

28 643 (2.80)

27 175 (2.00)

<0.001

Small sized

121 579 (11.6)

153 550 (11.4)

<0.001

Medium sized

268 472 (25.7)

339 944 (25.2)

Large sized

654 481 (62.7)

856 433 (63.4)

Northeast

218 917 (20.9)

284 809 (21.0)

Midwest or North Central

243 442 (23.2)

313 211 (23.1)

South

417 892 (39.9)

529 978 (39.2)

West

167 157 (16.0)

225 372 (16.7)

Hospital-related characteristics
Hospital bed size

Hospital region
<0.001

Hospital teaching status
Rural

107 021 (10.2)

131 045 (9.7)

Urban nonteaching

425 875 (40.8)

544 454 (40.3)

Urban teaching

511 636 (49.0)

674 428 (50.0)

<0.001

*Term used by Healthcare Cost and Utilization Project (HCUP) database.

decreased (20.9% in 2002 versus 7.7% in 2015,
Ptrend<0.001). A similar pattern was observed among
men with an observed increase in both endovascular
revascularization (4.7% in 2002 versus 19.1% in 2015,
Ptrend<0.001) and hybrid revascularization (2.5% in 2002
versus 9.5% in 2015, Ptrend<0.001), but a reduction in

surgical revascularization (22.6% in 2002 versus 9.5%
in 2015, Ptrend<0.001) (Figure 1).

In-Hospital Outcomes
In the unadjusted analysis, women had a higher
incidence of in-
hospital mortality, postoperative
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Figure 1. Summary for the findings of the study.
Temporal trend in hospitalizations and revascularization modalities for critical limb ischemia (CLI) among women and men. NIS,
National Inpatient Sample; OR, odds ratio.

hemorrhage, need for blood transfusion, postoperative
infection, ischemic stroke, and discharge to facilities
compared with men. Women were less likely to undergo major or minor amputations and had a lower incidence of AKI but a higher incidence of amputation-free
survival (Table 2). These findings remained consistent
in the multivariable logistic regression model adjusting
for the patient-and hospital-related characteristics as
well as the revascularization strategy. The secondary
analysis using the propensity-score matching model
also demonstrated similar findings (Table S3). Women
had higher rates of in-hospital mortality across the various racial and ethnic groups (Table S4).
On subgroup analysis according to age, women aged
≥50 years had higher adjusted in-hospital mortality compared with men (adjusted OR, 1.08; 95% CI, 1.04–1.12),
but there was no difference in the adjusted in-hospital
mortality rates between women and men aged <50 years
(adjusted OR, 1.07; 95% CI, 0.87–
1.32). In addition,
women had higher adjusted postoperative hemorrhage

in the subgroup of those aged ≥50 years (adjusted OR,
1.19; 95% CI, 1.16–1.22) and <50 years (adjusted OR,
1.23; 95% CI, 1.10–1.37) compared with men (Figure S1).
Women aged ≥50 years had higher adjusted in-hospital
mortality rates (adjusted OR, 2.55; 95% CI, 2.12–3.06)
and postoperative hemorrhage (adjusted OR, 1.15; 95%
CI 1.03–1.28) compared with women aged <50 years.
Among admissions in urban areas, adjusted in-
hospital mortality (adjusted OR, 1.08; 95% CI, 1.04–
1.12) and postoperative hemorrhage (adjusted OR,
1.19; 95% CI, 1.16–1.22) was higher in women versus
men. However, there was no significant difference in in-
hospital mortality between women versus men in rural
areas (adjusted OR, 0.97; 95% CI, 0.84–1.10) (Figure S1).

Outcomes of Endovascular Versus
Surgical Revascularization
Among women with CLI who underwent either endovascular or surgical intervention (n=297 658), 128 604
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Figure 2. Temporal trends of in-hospital mortality for hospitalization with critical limb ischemia
(CLI) among women and men.
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who had endovascular revascularization were matched
with 127 353 who had surgical revascularization. The
absolute standardized differences for the patient-and
hospital-related characteristics were <10% in both groups
(Figure S2A). Compared with surgical revascularization,
endovascular revascularization was associated with a
lower incidence of in-hospital mortality, minor amputation,
postoperative hemorrhage, need for blood transfusion,
postoperative infection, and discharge to facilities, but a
higher incidence of major amputation and AKI (Table 3). In
addition, endovascular revascularization was associated
with a shorter length of stay (5 days [interquartile range,

2–10 days] versus 7 days [interquartile range, 4–13 days],
P<0.001).
Similarly, propensity analysis matched 162 857 male
patients with CLI undergoing endovascular revascularization and 161 498 undergoing surgical revascularization.
There were minimal differences (ie, <10%) in the absolute standardized differences after matching (Figure 2B).
Endovascular revascularization was associated with a
lower incidence of in-
hospital mortality, postoperative
hemorrhage, need for blood transfusion, postoperative
infection, length of stay, and discharge to facilities, but a
higher incidence of major amputation and AKI (Table 4).

Table 2. In-Hospital Outcomes Among Women Versus Men With Critical Limb Ischemia
Incidences, %
Outcome

Women

Men

Unadjusted
odds ratio

95% CI

Adjusted odds
ratio*

95% CI

P value

Mortality

3.7

3.2

1.13

1.10–1.17

1.07

1.03–1.11

<0.001

Amputation-free survival

81.9

81.2

1.05

1.03–1.06

1.10

1.10–1.12

<0.001

Major amputation

15.3

16.3

0.92

0.91–0.94

0.88

0.86–0.89

<0.001

Minor amputation

9.8

14.7

0.63

0.62–0.65

0.66

0.65–0.67

<0.001

Postoperative infection

2.2

2.0

1.10

1.06–1.15

1.20

1.14–1.25

<0.001

Postoperative hemorrhage

8.0

7.0

1.16

1.13–1.18

1.19

1.16–1.22

<0.001

Blood transfusion

18.1

15.6

1.19

1.17–1.21

1.17

1.15–1.19

<0.001

Acute myocardial infarction

2.9

3.1

0.95

0.92–0.99

1.02

0.98–1.06

0.24

Ischemic stroke

0.9

0.7

1.27

1.19–1.35

1.20

1.12–1.29

<0.001

Acute kidney injury

11.2

12.5

0.88

0.87–0.90

0.86

0.84–0.88

<0.001

Facility discharge

40.2

35.2

1.24

1.22–1.25

1.04

1.03–1.06

<0.001

*Multivariate logistic regression model adjusting for patient-and hospital-related characteristics and revascularization strategy.
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Table 3. Propensity-Matched Outcomes of Endovascular Versus Surgical Revascularization Among Women With Critical
Limb Ischemia
Incidences, %
Outcome

Endovascular

Surgical

Odds ratio

95% CI

P value

Mortality

2.3

2.7

0.84

0.75–0.95

0.004

Major amputation

6.5

5.6

1.17

1.09–1.26

<0.001

Minor amputation

11.7

12.5

0.93

0.88–0.98

0.01

Postoperative infection

1.2

3.2

0.37

0.33–0.43

<0.001

Postoperative hemorrhage

10.1

16.1

0.58

0.55–0.62

<0.001

Blood transfusion

14.0

29.4

0.39

0.37–0.41

<0.001

Acute kidney injury

10.1

8.0

1.29

1.21–1.37

<0.001

Discharge to facility

29.6

39.7

0.64

0.61–0.67

<0.001

DISCUSSION
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In this nationally representative observational analysis
of ≈2.4 million hospitalizations with CLI, we found that
women with CLI were older and had a higher prevalence of certain cardiovascular risk factors such as
obesity and hypertension compared with men. The
rates of hospitalizations for CLI did not change among
women but increased in men. Women with CLI were
less likely to undergo any revascularization compared
with men. Furthermore, women with CLI had a higher
incidence of adjusted in-
hospital mortality, bleeding
complications, and discharge to facilities compared
with men. Endovascular revascularization was associated with lower adjusted in-hospital mortality among
women and men, compared with surgical revascularization. These findings suggest that although the rates
of CLI might be higher among men, the prevalence
of cardiovascular risk factors and revascularization-
related complications are likely higher among women,
and women with CLI are less likely to receive any
revascularization.
Prior studies exploring the sex differences among
patients with PAD showed that women are older
and have a higher prevalence of hypertension and

obesity10,11; however, these studies included only
a small proportion of patients with CLI. Our findings
extend this knowledge to a large cohort and confirm
the trends seen in earlier studies. A prior analysis has
shown that the rates of CLI hospitalizations remained
constant from 2003 to 2011 in the United States.17 In
this study, we showed that the rates of CLI hospitalizations did not change among women but have modestly
increased among men. This could be attributed to the
hesitancy for hospital admittance in patients with CLI
who are women or less serious presentation among
women, requiring hospitalization less often. Similar to
prior CLI studies that had a predominant male representation,21,22 we found that the rates of revascularization were overall low (<35%), but lower among women
compared with men. This is concerning given that revascularization has been associated with lower mortality, as demonstrated in our analysis, and improved
quality of life in this high-risk population.7,21 This further highlights the sex-related gaps in evidence-based
therapies that has been previously demonstrated in
other cardiovascular diseases.23,24 A previous analysis of the reduction of atherothrombosis for continued health (REACH) registry has shown that risk factor
control is suboptimal among women compared with

Table 4. Propensity-Matched Outcomes of Endovascular Versus Surgical Revascularization Among Men With Critical Limb
Ischemia
Incidences, %
Outcome

Endovascular

Surgical

Odds ratio

95% CI

P value

Mortality

1.9

2.3

0.83

0.75–0.92

0.001
<0.001

Major amputation

7.6

5.9

1.32

1.23–1.40

Minor amputation

18.2

17.8

1.02

0.98–1.07

0.28

Postoperative infection

1.2

2.7

0.43

0.38–0.48

<0.001

Postoperative hemorrhage

7.5

12.9

0.55

0.52–0.58

<0.001

Blood transfusion

11.1

22.4

0.43

0.41–0.46

<0.001

Acute kidney injury

11.5

8.9

1.34

1.27–1.41

<0.001

Discharge to facility

27.3

32.7

0.77

0.74–0.80

<0.001
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men with PAD.25 Reassuringly, we found that the rates
of in-hospital mortality are decreasing among women
and men. This might be related to the rise in the rates
of revascularization procedures, as well as the improvements in secondary preventative strategies including smoking cessation, statin therapy, and cardiac
rehabilitation.15,21,26
Evidence on sex-
specific differences in the outcomes of patients with PAD have been controversial
and mostly noncontemporary.27–29 A sex-specific analysis of the examining use of ticagrelor in peripheral
artery disease (EUCLID) trial found that women had
a lower risk of all-cause mortality, but similar risk of
limb adverse events at a mean of 30 months.10 Among
studies focusing on patients with PAD who underwent endovascular revascularization, women were
found to have higher rates of bleeding and vascular
complications.8 However, the rate of in-hospital mortality was similar in one study,8 and long-term mortality
was higher among women in another study.11 Studies
evaluating sex-
specific differences among patients
with CLI have been limited.14,30 One study comparing
the outcomes after surgical interventions showed that
women had lower patency rates after bypass surgery.14
Another single-
center study of 219 patients (44%
women) demonstrated that women had higher rates
of the composite of mortality, myocardial infarction, or
stroke, and lower rates of postprocedural patency for
infrainguinal endovascular interventions.30 In our study,
which focused on patients with CLI, we found that
women had higher rates of in-hospital mortality, bleeding complications, but a lower rate of amputations and
AKI. Several factors could contribute to these findings,
such as the smaller blood vessel diameter along with
the higher prevalence of more complex and multilevel
disease among women.6,30 Importantly, we found that
the higher rates of mortality and bleeding complications among women were mainly observed in those
aged ≥50 years (ie, likely postmenopausal), supporting the hypothesis of the protective role for estrogen
against potential limb ischemia in women.31
Randomized trial data comparing endovascular
therapy versus surgical interventions are scarce.32
The bypass versus angioplasty in severe ischaemia
of the leg (BASIL) trial demonstrated that an endovascular approach was comparable to surgery for CLI.32
However, endovascular techniques have evolved since
the BASIL trial. Furthermore, sex-specific differences
in the outcomes of both strategies have not been assessed in the BASIL trial.32 In the propensity-matched
analysis, we showed that endovascular revascularization was associated with lower in-hospital mortality in
both women and men. These findings should only be
considered as hypothesis generating given the potential for selection bias. The ongoing best endovascular
versus best surgical therapy for patients with critical

Sex Differences in CLI

limb ischemia (BEST-CLI) trial is comparing the outcomes of endovascular and surgical revascularization
approaches among patients with CLI eligible for both
modalities.33 Hopefully, the BEST-CLI trial will recruit
a representative sample of women to evaluate sex
differences in outcomes with both revascularization
strategies.
The strengths of this analysis are driven from the large
sample size with national representation, in a more contemporary population than previous studies. However,
the findings of this analysis should be interpreted in the
context of certain limitations. First, this is an observational nonrandomized study. Although we adjusted for
potential confounders and conducted several statistical
models, the risk of unmeasured confounding could not
be excluded. Second, the NIS lacks data on outcomes
beyond the index hospitalization. Specifically, for those
with CLI that was untreated, there is no information on
their long-term outcomes, and those untreated were
more likely to be women. Third, the NIS is an administrative database that relies on ICD-9-CM codes, and
thus is subject to miscoding and undercoding. Fourth,
we did not have access to important clinical data, because imaging, extent of the disease, and medical therapies administrated during the hospitalization were not
available. Fifth, data on menopausal state and estrogen
replacement therapy were not available in this data set,
so a subgroup analysis for age <50 versus ≥50 years
was performed, which is the mean age of menopause
in the United States for the past 2 decades.34 Sixth,
this analysis was not designed to directly compare the
outcomes of different revascularization strategies (ie,
endovascular or surgical) between women and men.
Finally, the clinical reasoning for choosing one revascularization technique versus the other could not be determined. We attempted to mitigate this by performing
a propensity-matched model.

CONCLUSIONS
In this nationwide contemporary analysis of CLI hospitalizations, we demonstrated that women with CLI
were older and had a higher prevalence of certain cardiovascular risk factors such as obesity and hypertension compared with men. The rates of hospitalizations
for CLI did not change among women but increased in
men. Women with CLI were less likely to undergo any
revascularization compared with men, but the trends
of revascularization have been increasing among both
sexes, particularly endovascular revascularization.
Women with CLI had a higher incidence of adjusted
in-hospital mortality, bleeding complications, and discharge to facilities compared with men. Endovascular
revascularization was associated with lower adjusted
in-
hospital mortality among both women and men,
compared with surgical revascularization, although the
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interpretation of this finding is limited by the observational nature of the study.
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Table S1. International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9- CM) codes
used to identify the baseline comorbidities, procedures, and in-hospital outcomes.

Critical limb ischemia
Atherosclerosis of native arteries of extremities
-with rest pain

440.22

-with gangrene

440.24

-with ulceration

440.23, 707.9

Critical limb ischemia if following code is present along
with a primary diagnosis code for PAD*

Gangrene

785.4

Ulcer of lower limb (includes trophic ulcer)

707.10, 707.11, 707.12, 707.13, 707.14,
707.15, 707.19
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Acute osteomyelitis of pelvic region and thigh

730.05

Acute osteomyelitis of lower extremity

730.06

Acute osteomyelitis of ankle and foot

730.07

Chronic osteomyelitis of pelvic region and thigh

730.15

Chronic osteomyelitis of lower extremity

730.16

Chronic osteomyelitis of ankle and foot

730.17

Cellulitis of lower extremity except foot

682.6

Cellulitis of foot except toes

682.7

Cellulitis of toes

681.1

*Primary PAD diagnosis
Atherosclerosis of native arteries of extremities with

440.2 (440.20-440.24, 440.29)

intermittent claudication, rest pain, ulceration,
gangrene or unspecified symptoms.
Atherosclerosis of bypass graft of extremities

440.3 (440.0-440.32)

Atherosclerosis- generalized or unspecified

440.9

Atherosclerosis of Aorta

440.0

Diabetes mellitus with peripheral circulatory

249.70, 249.71, 250.70-250.73

disorders
Peripheral angiopathy in other diseases

443.81

Peripheral vascular disease, unspecified

443.9

Buerger’s disease

443.1

Arterial embolism/ thrombosis of lower extremity

444.22, 444.81

or iliofemoral artery
Surgical Revascularization
Aorto-iliac femoral bypass

39.25

Peripheral bypass

39.29

Incision of lower limb arteries

38.08

Endarterectomy of abdominal arteries

38.16

Endarterectomy of lower limb arteries

38.18

Resection of vessel with anastomosis

38.38

Resection of vessel with replacement

38.48

Endovascular revascularization
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Angioplasty or atherectomy of non-coronary vessel

39.50

Insertion of non-drug-eluting, non-coronary artery

39.90

stent
Insertion of drug eluting peripheral vessel stent

00.55

Major amputation of lower extremity
Lower limb amputation

84.10

Disarticulation of ankle

84.13

Amputation of ankle through malleoli of tibia and

84.14

fibula
Other amputation-below knee

84.15

Disarticulation of knee

84.16

Amputation above knee

84.17

Revision of amputation stump

84.3

Minor amputation of lower extremity
Toe amputation

84.11

Trans metatarsal amputation

84.12

Vascular procedures, non-specific, only used in
conjunction with lower extremity procedure codes
Procedure on single vessel

00.40

Procedure on two vessels

00.41

Procedure on three vessels

00.42

Procedure on ≥ 4 vessels

00.43

Procedure on vessel bifurcation

00.44

Insertion of one vascular stent

00.45

Insertion of two vascular stents

00.46

Insertion of three vascular stents

00.47

Insertion of ≥ 4 vascular stents

00.48

Non-ST-elevation myocardial infarction

410.7x

ST-elevation myocardial infarction

410.1x, 410.2x, 410.3x, 410.4x, 410.5x,
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410.6x, 410.8x and 410.9x
Prior myocardial infarction

412.0

Previous percutaneous coronary intervention

V45.82

Previous coronary artery bypass grafting

V45.81

Previous CVA

V12.54

Carotid artery disease

433.10

Cardiogenic shock

785.51

Cardiac arrest

CCS-107

Post-op hemorrhage

998.11, 998.12, 285.1

Transfusion

99.01-99.09

Acute stroke

CCS-100

Respiratory complications

997.3, 997.31, 997.32, 997.39

Permanent pacemaker

37.80 37.83

Acute kidney injury

584

Vascular complications

39.31, 39.41, 39.49, 39.52, 39.53,
39.56, 39.57, 39.58, 39.59, 39.79
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Table S2. List of variables used in the propensity score matching analysis comparing the
revascularization strategies.

Age, race, diabetes mellitus, hypertension, obesity, history of heart failure, chronic
lung disease, pulmonary circulation disorders, chronic liver disease, CKD, chronic
anemia, coagulopathy, hypothyroidism, history of smoking, coronary artery
disease, prior MI, history of implantable cardiac defibrillator, history of cardiac
pacemaker, prior stroke, prior PCI, prior CABG, hospital bed-size, hospital region,
hospital teaching status.
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Table S3. In-hospital outcomes among women versus men with critical limb ischemia after propensity score matching
Outcome

Incidences %
Women
Men

Adjusted odds
ratio

95% confidence
interval

P-value

Mortality

3.7%

3.4%

1.09

1.07-1.10

<0.001

Amputation free survival

82.0%

81.1%

1.06

1.05-1.07

<0.001

Major amputation

15.3%

16.4%

0.92

0.91.0.93

<0.001

Minor amputation

10.0%

14.3%

0.67

0.66-0.67

<0.001

Post-operative infection

2.3%

1.9%

1.17

1.15-1.20

<0.001

Post-operative hemorrhage

8.1%

7.1%

1.16

1.15-1.18

<0.001

Blood transfusion

18.3%

16.0%

1.17

1.17-1.18

<0.001

Acute myocardial infarction

3.0%

3.0%

0.99

0.97-1.00

0.10

Ischemic stroke

0.9%

0.7%

1.25

1.22-1.29

<0.001

Acute kidney injury
Facility discharge

11.3%

12.9%

0.86

0.85-0.87

<0.001

39.5%

37.4%

1.09

1.09-1.10

<0.001
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Table S4. Sex-related differences in in-hospital mortality across various racial groups.

Outcome

Incidences %
Women
Men

Odds ratio

95% confidence interval

P-value

White
Mortality

3.5%

3.3%

1.083

1.063

1.103

<0.001

3.8%

3.2%

1.191

1.151

1.233

<0.001

3.7%

3.1%

1.206

1.149

1.266

<0.001

Black
Mortality
Hispanic
Mortality
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Figure S1. Subgroup analyses for in-hospital mortality and post-operative hemorrhage comparing age 50 years versus <50 years, and urban versus rural hospitals.

In-hospital mortality

Age<50
Age≥50

Age<50

Post-operative hemorrhage

Age≥50

Rural
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In-hospital mortality

Urban

Post-operative hemorrhage

Rural
Urban

OR

0

0.5

Less likely in women

1

1.5

More likely in women

2

2.5

3

(A)

(B)

Standardized diﬀerences before matching
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Figure S2. Absolute standardized differences for the patient and hospital-related characteristics included in the propensity matched model comparing endovascular
revascularization versus surgical revascularization among (A) women and (B) men.

